Prophylactic antibiotics in first-trimester abortions: a clinical, controlled trial
- PMID: 7011035
- DOI: 10.1016/0002-9378(81)90488-9
Prophylactic antibiotics in first-trimester abortions: a clinical, controlled trial
Abstract
The efficacy of prophylactic antibiotic therapy in induced first-trimester abortions was investigated in a double-blind study. Of the 493 women in the study, 254 received doses of 2 million IU of penicillin G intramuscularly one-half hour before and 3 hours after the procedure, followed by 350 mg of pivampicillin three times daily for 4 days, and 239 women received corresponding doses of placebo. The incidence of pelvic infectious complications was 5.5% in the treated group and 10.9% in the control group (p = 0.05). The difference could be attributed to a selective prophylactic effect in women who had earlier suffered from pelvic inflammatory disease (N = 105). The rate of infection in this group was 22.4% among those receiving placebo and 2.1% among those receiving antibiotics (p = 0.006). Prophylactic administration of antibiotics for first-trimester abortions should be used in women who have earlier had pelvic inflammatory disease.
PIP: The efficacy of prophylactic antibiotic therapy in induced first trimester abortions was investigated in a double-blind study. Of the 493 women in the study, 254 received dosed of 2 million IU of penicillin G intermuscularly 1/2 hour before and 3 hours after the procedure, followed by 350 mg of pivampicillin 3 times daily for 4 days, and 239 women received corresponding doses of placebo. The incidence of pelvic infectious complications was 5.5% in the treated group and 10.9% in the control group (P=0.05). The difference could be attributed to a selective prophylactic effect in women who had earlier suffered from (PID) pelvic inflammatory disease (N=105). The rate of infection in this group was 22.4% among those receiving placebo and 2.1% among those receiving antibiotics (P=0.006). Prophylactic administration of antibiotics for first trimester abortions should be used in women who have earlier had PID.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
